BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6092903)

  • 1. Free radicals in quinone-containing antitumor agents. Electrochemical reduction of diaziquone (2,5-diaziridine-3,6-bis(carboethoxyamino)-1,4 -benzoquinone) and two analogues.
    Gutierrez PL; Fox BM; Mossoba MM; Bachur NR
    Mol Pharmacol; 1984 Nov; 26(3):582-6. PubMed ID: 6092903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free radicals in quinone containing antitumor agents. The nature of the diaziquone (3,6,-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone) free radical.
    Gutierrez PL; Bachur NR
    Biochim Biophys Acta; 1983 Jul; 758(1):37-41. PubMed ID: 6305426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical activation of AZQ [3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone] to its free radical species.
    Gutierrez PL; Friedman RD; Bachur NR
    Cancer Treat Rep; 1982 Feb; 66(2):339-42. PubMed ID: 6275990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electron spin resonance of electrochemically generated free radicals from diaziquone and its derivatives.
    Gutierrez PL; Fox BM; Mossoba MM; Egorin MJ; Nakazawa H; Bachur NR
    Biophys Chem; 1985 Jun; 22(1-2):115-23. PubMed ID: 2992620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism(s) of bioreductive activation. The example of diaziquone (AZQ).
    Gutierrez PL
    Free Radic Biol Med; 1989; 6(4):405-45. PubMed ID: 2651223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of diaziquone free radicals on the in vitro activity of diaziquone.
    Nguyen B; Biswal S; Gutierrez PL
    Xenobiotica; 1988 May; 18(5):593-602. PubMed ID: 2840783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the structural and cytotoxic activity of novel 2,5-bis(carboethoxyamino)-3,6-diaziridinyl-1,4-benzoquinone analogues.
    Dzielendziak A; Butler J; Hoey BM; Lea JS; Ward TH
    Cancer Res; 1990 Apr; 50(7):2003-8. PubMed ID: 2156610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of ascorbic acid on the free-radical metabolism of xenobiotics: the example of diaziquone.
    Gutierrez PL
    Drug Metab Rev; 1988; 19(3-4):319-43. PubMed ID: 3068033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction and glutathione conjugation reactions of N-acetyl-p-benzoquinone imine and two dimethylated analogues.
    Rosen GM; Rauckman EJ; Ellington SP; Dahlin DC; Christie JL; Nelson SD
    Mol Pharmacol; 1984 Jan; 25(1):151-7. PubMed ID: 6323948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reductive activation of the antitumor drug RH1 to its semiquinone free radical by NADPH cytochrome P450 reductase and by HCT116 human colon cancer cells.
    Hasinoff BB; Begleiter A
    Free Radic Res; 2006 Sep; 40(9):974-8. PubMed ID: 17015278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductive activation of diaziquone and possible involvement of free radicals and the hydroquinone dianion.
    Gutierrez PL; Biswal S; Nardino R; Biswal N
    Cancer Res; 1986 Nov; 46(11):5779-85. PubMed ID: 3019536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reduction of anti-tumour diaziridinyl benzoquinones.
    Butler J; Hoey BM; Lea JS
    Biochim Biophys Acta; 1987 Aug; 925(2):144-9. PubMed ID: 3040109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diaziquone as a potential agent for photoirradiation therapy: formation of the semiquinone and hydroxyl radicals by visible light.
    Mossoba MM; Gutierrez PL
    Biochem Biophys Res Commun; 1985 Oct; 132(1):445-52. PubMed ID: 2998365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of metabolism and oxidation-reduction cycling in the cytotoxicity of antitumor quinoneimines and quinonediimines.
    Powis G; Hodnett EM; Santone KS; See KL; Melder DC
    Cancer Res; 1987 May; 47(9):2363-70. PubMed ID: 3032421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical species.
    Gutierrez PL; Egorin MJ; Fox BM; Friedman R; Bachur NR
    Biochem Pharmacol; 1985 May; 34(9):1449-55. PubMed ID: 3994758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemical reduction of diaziquone: products and free radical intermediates.
    Gutierrez PL; Balachandran Nayar MS; Nardino R; Callery PS
    Chem Biol Interact; 1987; 64(1-2):23-37. PubMed ID: 2826025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ascorbic acid on biologically obtained diaziquone free radicals.
    Gutierrez PL; Egorin MJ; Davis TA; Bachur NR
    Biochem Pharmacol; 1985 Jul; 34(13):2394-7. PubMed ID: 2990485
    [No Abstract]   [Full Text] [Related]  

  • 18. DNA strand scission and cross-linking by diaziridinylbenzoquinone (diaziquone) in human cells and relation to cell killing.
    Szmigiero L; Erickson LC; Ewig RA; Kohn KW
    Cancer Res; 1984 Oct; 44(10):4447-52. PubMed ID: 6467204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trace detection of hydroxyl radicals during the redox cycling of low concentrations of diaziquone: a new approach.
    Li B; Blough NV; Gutierrez PL
    Free Radic Biol Med; 2000 Sep; 29(6):548-56. PubMed ID: 11025198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor agents 4. Characterization of free radicals produced during reduction of the antitumor drug 5H-pyridophenoxazin-5-one: an EPR study.
    Alberti A; Bolognese A; Guerra M; Lavecchia A; Macciantelli D; Marcaccio M; Novellino E; Paolucci F
    Biochemistry; 2003 Oct; 42(41):11924-31. PubMed ID: 14556623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.